Question: An analyst has gathered data on valuation multiples for Merck (MRK) and three other pharmaceutical companles, which will serve as comparable firms: Pfizer (PFE), Ell

An analyst has gathered data on valuation multiples for Merck (MRK) and three other pharmaceutical companles, which will serve as comparable firms: Pfizer (PFE), Ell Lilly (LLY), and Sanof- Aventis (SNY Valuation multiples PFE MRK SNY Comparable Company symbol Price/Earnings9.08 Price/Book Price/Sales Enterprise LLY 1.96 2.78 9.93 15.42 1.48 2.05 5.64 846 3.62 1.63 4.94 10.15 1.12 1.87 5.33 average 11.34 2.07 1.85 5.30 Value/EBITDA The analyst is estlmating the value of the equity Insol, a private pharmaceutical company that has $200M In EBITDA and Is financed with $300M In debt. Using the comparable average, the equity of this company would be valued at O $480M O $560M O $760M O $1,060M
Step by Step Solution
There are 3 Steps involved in it
Get step-by-step solutions from verified subject matter experts
